PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PRHSX vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


PRHSXXLV
YTD Return11.44%9.17%
1Y Return16.52%17.76%
3Y Return (Ann)-4.77%4.88%
5Y Return (Ann)4.34%10.98%
10Y Return (Ann)3.06%9.94%
Sharpe Ratio1.221.75
Sortino Ratio1.652.45
Omega Ratio1.231.32
Calmar Ratio0.622.07
Martin Ratio5.967.72
Ulcer Index2.93%2.39%
Daily Std Dev14.25%10.51%
Max Drawdown-47.79%-39.18%
Current Drawdown-16.37%-6.02%

Correlation

-0.50.00.51.00.8

The correlation between PRHSX and XLV is 0.78, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

PRHSX vs. XLV - Performance Comparison

In the year-to-date period, PRHSX achieves a 11.44% return, which is significantly higher than XLV's 9.17% return. Over the past 10 years, PRHSX has underperformed XLV with an annualized return of 3.06%, while XLV has yielded a comparatively higher 9.94% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-2.00%0.00%2.00%4.00%6.00%8.00%10.00%JuneJulyAugustSeptemberOctoberNovember
6.07%
2.98%
PRHSX
XLV

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


PRHSX vs. XLV - Expense Ratio Comparison

PRHSX has a 0.80% expense ratio, which is higher than XLV's 0.12% expense ratio.


PRHSX
T. Rowe Price Health Sciences Fund
Expense ratio chart for PRHSX: current value at 0.80% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.80%
Expense ratio chart for XLV: current value at 0.12% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.12%

Risk-Adjusted Performance

PRHSX vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PRHSX
Sharpe ratio
The chart of Sharpe ratio for PRHSX, currently valued at 1.22, compared to the broader market0.002.004.001.22
Sortino ratio
The chart of Sortino ratio for PRHSX, currently valued at 1.65, compared to the broader market0.005.0010.001.65
Omega ratio
The chart of Omega ratio for PRHSX, currently valued at 1.23, compared to the broader market1.002.003.004.001.23
Calmar ratio
The chart of Calmar ratio for PRHSX, currently valued at 0.62, compared to the broader market0.005.0010.0015.0020.000.62
Martin ratio
The chart of Martin ratio for PRHSX, currently valued at 5.96, compared to the broader market0.0020.0040.0060.0080.00100.005.96
XLV
Sharpe ratio
The chart of Sharpe ratio for XLV, currently valued at 1.75, compared to the broader market0.002.004.001.75
Sortino ratio
The chart of Sortino ratio for XLV, currently valued at 2.45, compared to the broader market0.005.0010.002.45
Omega ratio
The chart of Omega ratio for XLV, currently valued at 1.32, compared to the broader market1.002.003.004.001.32
Calmar ratio
The chart of Calmar ratio for XLV, currently valued at 2.07, compared to the broader market0.005.0010.0015.0020.002.07
Martin ratio
The chart of Martin ratio for XLV, currently valued at 7.72, compared to the broader market0.0020.0040.0060.0080.00100.007.72

PRHSX vs. XLV - Sharpe Ratio Comparison

The current PRHSX Sharpe Ratio is 1.22, which is lower than the XLV Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of PRHSX and XLV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
1.22
1.75
PRHSX
XLV

Dividends

PRHSX vs. XLV - Dividend Comparison

PRHSX has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.54%.


TTM20232022202120202019201820172016201520142013
PRHSX
T. Rowe Price Health Sciences Fund
0.00%0.00%0.00%0.00%0.00%0.06%0.00%0.00%0.00%0.00%0.00%0.00%
XLV
Health Care Select Sector SPDR Fund
1.54%1.59%1.47%1.33%1.49%2.17%1.58%1.47%1.60%1.43%1.35%1.52%

Drawdowns

PRHSX vs. XLV - Drawdown Comparison

The maximum PRHSX drawdown since its inception was -47.79%, which is greater than XLV's maximum drawdown of -39.18%. Use the drawdown chart below to compare losses from any high point for PRHSX and XLV. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-16.37%
-6.02%
PRHSX
XLV

Volatility

PRHSX vs. XLV - Volatility Comparison

T. Rowe Price Health Sciences Fund (PRHSX) has a higher volatility of 4.15% compared to Health Care Select Sector SPDR Fund (XLV) at 3.06%. This indicates that PRHSX's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctoberNovember
4.15%
3.06%
PRHSX
XLV